Georg Börtlein is the founder of HighLife. HighLife has raised $47M in total funding. Latest round: Series B. Backed by LivaNova PLC. Based in Paris, France.
Georg Bortlein is the founder and President of HighLife SAS, a Paris-based medtech company developing a transcatheter mitral valve replacement (TMVR) system. He previously participated in the company's seed financing and continues to support HighLife as it advances clinical studies.
Full founder directory · Investor directory · Company funding database · Fundraising library